Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN01915371
ISRCTN01915371
Completed
未知

Weight loss in obese women with Polycystic Ovary Syndrome (PCOS): a randomised controlled trial

Robert Gordon University (UK)0 sites66 target enrollmentApril 13, 2011
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Robert Gordon University (UK)
Enrollment
66
Status
Completed
Last Updated
8 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 13, 2011
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Robert Gordon University (UK)

Eligibility Criteria

Inclusion Criteria

  • •1\. Obese women body mass index (BMI) \> 30 kg/m2
  • •2\. Aged between 20\-40 years old who wish to conceive and have polycystic ovary syndrome (PCOS) as defined by the Rotterdam criteria, (2003\)

Exclusion Criteria

  • •1\. Previously diagnosed diabetics (both types 1 and 2\)
  • •2\. History of renal disorder, hepatic disease, thyroid disease or cancer
  • •3\. Eating disorders
  • •4\. Weight altering medication
  • •5\. Weight loss \> 2% in the last 3 months
  • •6\. Major cardiovascular or cerebrovascular event in the last 6 months
  • •7\. Pregnancy or lactation
  • •8\. Miscarriage in the last 3 months
  • •9\. Following contraception methods
  • •10\. Cardiac dysrhythmia

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
ew strategies to lose weight for women with polycystic ovary syndromeoverweight and obese women with polycystic ovary syndrome (PCOS) at risk for metabolic syndromeTherapeutic area: Body processes [G] - Metabolic Phenomena [G03]
EUCTR2018-000677-77-BEniversity Hospital Leuven60
Not yet recruiting
Not Applicable
Impact of lifestyle modifications in polycystic ovarian syndromePolycystic ovarian syndromeMetabolic and Endocrine - Other metabolic disordersReproductive Health and Childbirth - Other reproductive health and childbirth disorders
ACTRN12612000680864Tawam Hospital100
Completed
Phase 4
Weight Maintenance With Dipeptidyl Peptidase 4 (DPP4) Inhibitor Sitagliptin in Combination With Metformin After Liragludite Induced Weight LossPolycystic Ovary SyndromeBody Weight
NCT02941445University Medical Centre Ljubljana24
Completed
Not Applicable
Weight Loss Intervention in Women With PCOSPolycystic Ovary SyndromeOverweight and Obesity
NCT03677362University of Kansas Medical Center12
Completed
Not Applicable
The Changes of Body Fat Distribution in Obese Patients With PCOS After LSGPolycystic Ovary Syndrome
NCT04690634Shanghai 10th People's Hospital153